Inventor
JR., ALEXANDER D. MACKERELL
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations37%
C07DHeterocyclic compounds32%
A61KPreparations for medical, dental or toiletry purposes26%
C07CAcyclic or carbocyclic compounds5%
PatentTitleYear
12,404,259Inhibitors of extracellular signal-regulated kinase202512,202,810Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors202511,911,392Non-catalytic substrate-selective p38a-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof202411,911,393Non-catalytic substrate-selective p38alpha-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof202411,718,595Non-ATP/catalytic site p38 Mitogen Activated Protein Kinase inhibitors202311,634,381RUNX2 transcription factor inhibitors and uses thereof202311,357,781Non-catalytic substrate-selective, p38a-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to UNIV MARYLAND (7)· patent assignee history
2022–2024Patents assigned to US VETERANS AFFAIRS (4)· patent assignee history
2022–2025Based in US· patent location history
2025Patents assigned to GEN1E LIFESCIENCES INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV MARYLAND | 7 | 2022–2025 |
| US VETERANS AFFAIRS | 4 | 2022–2024 |
| GEN1E LIFESCIENCES INC | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2022–2025 |